Premier Alternatives

Frontier Bio

Hayward, CA · Founded 2018 · Privately Held (backing)

Developer of engineered tissue technologies designed to create human-compatible vascular grafts and tissue models. Frontier Bio is based in Hayward, CA and was founded in 2018. Its last reported valuation was $2.7 million in Sep 2019. It has raised $2.9 million.

Last reported valuation
$2.7M
Oct 2026
Priced at
—
Total raised
$2.9M
Last round
—

Frontier Bio key facts

as of Oct 2026
  • Developer of engineered tissue technologies designed to create human-compatible vascular grafts and tissue models.
  • Frontier Bio is valued at approximately $2.7M as of Oct 2026 (last reported valuation).
  • It has raised $2.9M; the latest was Equity Crowdfunding ($1.6M) in Mar 2026.
  • Notable investors include US National Science Foundation, StartX (US), Alchemist Accelerator, Berkeley SkyDeck, MicroVentures — 28 tracked in total.
  • 1 investment vehicle was formed to buy Frontier Bio shares in the last 12 months, per SEC Form D filings.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$2.7M

Frontier Bio's last reported valuation, Sep 2019. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Frontier Bio with a free account
  • ·The complete investor list: 28 names
  • ·Watch Frontier Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frontier Bio funding rounds

No rounds on record

No funding rounds for Frontier Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Vehicles formed to buy Frontier Bio shares

secondary demand · SEC Form D filings

In the last 12 months, 1 investment vehicle were formed to buy Frontier Bio shares. Most recent filing Jan 2026.

The vehicle list — each sponsor, filing date, amount sold and investor count — is a Pro table. Unlock the 1 vehicle →

Membership and data by Private Market View

Companies with the most vehicle activity →

Frontier Bio valuation

Frontier Bio's last reported valuation was $2.7 million in Sep 2019. No priced round, secondary trade or fund mark has surfaced since.

Institutional holders and vehicles

In the last 12 months, 1 investment vehicle was formed to buy Frontier Bio shares, per SEC Form D filings (most recent Jan 2026).

Frontier Bio investors

28 investors are on record for Frontier Bio, including US National Science Foundation, StartX (US), Alchemist Accelerator and Berkeley SkyDeck.

About Frontier Bio

Developer of engineered tissue technologies designed to create human-compatible vascular grafts and tissue models. The company's platform offers bioresorbable scaffolds, stem cell-based graft development, and lab-grown tissue models, enabling healthcare providers and research organizations to treat vascular conditions and conduct preclinical testing.

Sector
Healthcare
HQ
Hayward, CA, United States
Founded
2018
Employees
5
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.